Biocartis Group Stock Forecast - Period Momentum Indicator

BCART Stock  EUR 0.29  0.00  0.00%   
Biocartis Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Biocartis Group stock prices and determine the direction of Biocartis Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Biocartis Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
On November 21, 2024 Biocartis Group NV had Period Momentum Indicator of 0. Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Biocartis Group VolatilityBacktest Biocartis GroupTrend Details  

Biocartis Group Trading Date Momentum

On November 22 2024 Biocartis Group NV was traded for  0.29  at the closing time. The highest price during the trading period was 0.29  and the lowest recorded bid was listed for  0.29 . There was no trading activity during the period 1.0. Lack of trading volume on November 22, 2024 did not affect price variability. The overall trading delta to the current price is 0.00% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Biocartis Group to competition

Other Forecasting Options for Biocartis Group

For every potential investor in Biocartis, whether a beginner or expert, Biocartis Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biocartis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biocartis. Basic forecasting techniques help filter out the noise by identifying Biocartis Group's price trends.

Biocartis Group Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocartis Group stock to make a market-neutral strategy. Peer analysis of Biocartis Group could also be used in its relative valuation, which is a method of valuing Biocartis Group by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biocartis Group NV Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Biocartis Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Biocartis Group's current price.

Biocartis Group Market Strength Events

Market strength indicators help investors to evaluate how Biocartis Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocartis Group shares will generate the highest return on investment. By undertsting and applying Biocartis Group stock market strength indicators, traders can identify Biocartis Group NV entry and exit signals to maximize returns.

Pair Trading with Biocartis Group

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Biocartis Stock

Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.